Trademark: FMI 2053771
Word
FMI
ID
2053771
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
08 February 2019
Registration Date
08 February 2019
Renewal Date
08 February 2029
Owner(s)
Service
Goods and Services:
Class 42:
Hosting an online Internet website portal featuring links to scientific research data and information in the field of cancer treatment and diagnosis and clinical trials; providing collected and analyzed medical and scientific research information in the field of cancer genomics and cancer treatment.
Hosting an online Internet website portal featuring links to scientific research data and information in the field of cancer treatment and diagnosis and clinical trials; providing collected and analyzed medical and scientific research information in the field of cancer genomics and cancer treatment.
Class 44:
Providing information on patient medical test results from medical testing for diagnosis or treatment purposes via an Internet website portal; providing medical information via an Internet website portal featuring links; genomic and genetic and molecular medical testing for cancer diagnostic or treatment purposes; providing collected and analyzed medical information on cancer genomics and treatment; providing collected and analyzed medical information on cancer genomics and treatment, for diagnostic and treatment purposes; medical testing for cancer diagnostic or treatment purposes; providing medical information and data to healthcare professionals on cancer genomics and treatment and clinical trials; providing medical information featuring the collection and analysis of cancer-associated genetics and treatments; providing medical data to healthcare professionals on cancer genomics and treatments and clinical trials.
Providing information on patient medical test results from medical testing for diagnosis or treatment purposes via an Internet website portal; providing medical information via an Internet website portal featuring links; genomic and genetic and molecular medical testing for cancer diagnostic or treatment purposes; providing collected and analyzed medical information on cancer genomics and treatment; providing collected and analyzed medical information on cancer genomics and treatment, for diagnostic and treatment purposes; medical testing for cancer diagnostic or treatment purposes; providing medical information and data to healthcare professionals on cancer genomics and treatment and clinical trials; providing medical information featuring the collection and analysis of cancer-associated genetics and treatments; providing medical data to healthcare professionals on cancer genomics and treatments and clinical trials.